Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03562377
Brief Title: Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) (ECZTRA 5)

First Submitted : June 8, 2018
First Submitted that Met QC Criteria : June 8, 2018
First Posted : June 19, 2018

Results First Submitted : January 14, 2021
Results First Submitted that Met QC Criteria : February 15, 2021
Results First Posted : March 5, 2021

Certification/Extension First Submitted : September 9, 2020
Certification/Extension First Submitted that Met QC Criteria : February 15, 2021
Certification/Extension First Posted : March 5, 2021

Last Update Submitted that Met QC Criteria : February 15, 2021
Last Update Posted : March 5, 2021